Newt Gingrich

Newt Gingrich

Former Speaker of the House Newt Gingrich is the founder of the Center for Health Transformation ( and the author of Saving Lives & Saving Money.

The dominant model of the 21st century will be more choices with better quality at lower cost. This is already true in nearly every segment of the market and it is what the American consumer over the last decade has come to expect. However, in health care this market dynamic is absent.

Over the next quarter century, we will see as many technological and scientific advances as we did over the last hundred years, especially in health. Despite this, plagued by lack of quality systems, health care delivery has fallen woefully behind the trend toward innovation.

Consumers regularly use technologies that they take for granted. For example, when they use an automatic teller machine, an online bill paying service, Internet travel reservations, and even self-serve gasoline pumps, consumers have come to expect the high level of efficiency and accuracy that these expert systems routinely deliver.

Yet, at the doctor's office, patients are still handed paper prescriptions and almost no one has a single comprehensive electronic medical record. In fact, most people are likely to have multiple and probably forgotten paper medical records in any number of different offices and hospitals.

The technology for electronic prescriptions and medical records already exists and is being used successfully by a limited number of providers. Some hospitals are now using bar codes to ensure patient safety and will in fact save lives and money. But notice that this technology has been familiar to consumers for nearly two decades and still, despite the proven outcomes, it has yet to be deployed systemwide.

In fact, the application of numerous expert systems to health care could save numerous lives and billions of dollars. It is difficult not to conclude that the resistance to change is simply cultural.

A failed third-party-payer system has been at the heart of this problem. Fortunately however, the recent Medicare law signed by President Bush will begin to change this cultural dynamic. Health Savings Accounts (HSAs) that were included in the law represent the most important first step.

Because individuals will own these accounts and because they can accumulate earnings tax-free from pre-tax contributions, owners of HSAs have a real incentive to not only stay healthy but also to make better choices as consumers of health care.

Because insurance usually does not cover cosmetic and laser eye surgery, the consumer must pay the full cost of these procedures. The result is that consumers actively compare quality and price when choosing a provider. The consequence is that while health care costs have skyrocketed, cosmetic surgery costs have stayed below the consumer price index and laser eye surgery costs have fallen nearly 30 percent since being made widely available.

We need to employ the same market dynamics in health care so that not only would the industry be responsive to the patient, but the patient takes control of and responsibility for his own health by actively participating in his treatment options and making the choices to stay healthy in the first place.

But to make those decisions, patients will demand more information. What will be most important to educated health care consumers will be patient safety. Any political or legislative action will have to be implemented within this standard.

Therefore, it will be necessary for providers to develop expert systems to meet the safety standards required by consumers. That system will allow a patient to own and control his own electronic health record, enabling both patients and providers to access accurate and timely information about best practices so that they can jointly decide on treatment options likely to have the best outcomes while ensuring patients' personal privacy. Such a system would make electronic prescriptions and hospital order entry systems the industry standard.

If properly designed, the system will eventually migrate toward setting the innovation trend rather than trailing it.

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.